274
Participants
Start Date
November 30, 2016
Primary Completion Date
August 31, 2019
Study Completion Date
September 30, 2019
SNF472
Administered 3 times weekly by intravenous infusion through the dialysis machine in conjunction with the patient's dialysis sessions.
Placebo
Administered 3 times weekly by intravenous infusion through the dialysis machine in conjunction with the patient's dialysis sessions.
The Bronx
College Point
Córdoba
Bethlehem
Chesapeake
Lleida
Lleida
Lugo
Madrid
Asheville
Navarro
Oviedo
Hollywood
Miami
Miami Gardens
Tampa
Ocala
Knoxville
Santander
Brookhaven
Seville
Cincinnati
Valencia
Valencia
Roseville
Pontiac
Galdakao
Zaragoza
Wauwatosa
Evanston
Shreveport
Richardson
Arlington
Houston
Houston
San Antonio
Arvada
Westminster
Las Vegas
Reno
Los Angeles
Lynwood
Whittier
La Palma
Long Beach
Northridge
Granada Hills
Tarzana
San Dimas
Chula Vista
Escondido
San Diego
Riverside
Simi Valley
Bakersfield
Middlebury
Orange
Lauderdale Lakes
North Brunswick
Palma
Palma
Palma de Mallorca
Barcelona
Barcelona
Barcelona
Barcelona
Barcelona
Barcelona
Palma
Bradford
Manchester
Salford
Shrewsbury
Swansea
Westcliff-on-Sea
Collaborators (1)
Clinipace Worldwide
INDUSTRY
Sanifit Therapeutics S. A.
OTHER